958489-77-5

Upstream product

• 150255-96-2 (3‐cyanophenyl)boronic acid 
• 58534-94-4 2-fluoro-3-bromonitrobenzene 
• 958489-74-2 S-(3'-cyano-3-nitrobiphenyl-2-yl)-N-(1,1-dimethylethoxycarbonyl)-L-cysteine 
• 958489-75-3 S-(3-amino-3'-cyanobiphenyl-2-yl)-N-(1,1-dimethylethoxycarbonyl)-L-cysteine 
• 958489-73-1 2'-fluoro-3'-nitrobiphenyl-3-carbonitrile 
• 958489-76-4 3-[(3R)-3-{(1,1-dimethylethoxycarbonyl)amino}-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-9-yl]benzonitrile 

Downstream Products

• 958489-72-0 (2R,3R,4S,5R,6E)-N-[(3R)-9-(3-cyanophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide 

Relevant academic research and scientific papers

2-ALKOXY-3,4,5-TRIHYDROXYALKYLAMIDE-BENZOTHIAZEPINES PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF

The present invention relates to 2-alkoxy-3,4,5-trihydroxyalkylamide benzothiazepine compounds, to pharmaceutical compositions comprising such compounds, to methods of treatment comprising administering such compounds, to processes for the preparation of